Abstract
This study uses Medicare Part D drug utilization and spending data to estimate potential Part D program and beneficiary savings on brand-name medications excluded by pharmacy benefit managers for which generic substitutes are available.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cost Savings / economics*
-
Drug Substitution / economics*
-
Drugs, Generic / economics*
-
Health Expenditures*
-
Humans
-
Medicare
-
Medicare Part D / economics*
-
Organizational Policy
-
United States